These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB. J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673 [Abstract] [Full Text] [Related]
24. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus. Okin PM, Roman MJ, Devereux RB, Kligfield P. J Electrocardiol; 1996 May; 29 Suppl():256-61. PubMed ID: 9238409 [Abstract] [Full Text] [Related]
27. Comparison of usefulness of Sokolow and Cornell criteria for left ventricular hypertrophy in subjects aged <20 years versus >30 years. Grossman A, Prokupetz A, Koren-Morag N, Grossman E, Shamiss A. Am J Cardiol; 2012 Aug 01; 110(3):440-4. PubMed ID: 22534054 [Abstract] [Full Text] [Related]
28. Concealment of electrocardiographically based diagnosis of left ventricular hypertrophy by anasarca. Madias JE. Am J Hypertens; 2004 Oct 01; 17(10):897-903. PubMed ID: 15485751 [Abstract] [Full Text] [Related]
34. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension. Mahn JJ, Dubey E, Brody A, Welch R, Zalenski R, Flack JM, Ference B, Levy PD. Acad Emerg Med; 2014 Sep 01; 21(9):996-1002. PubMed ID: 25269580 [Abstract] [Full Text] [Related]
36. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population. Cuspidi C, Facchetti R, Bombelli M, Sala C, Grassi G, Mancia G. J Hypertens; 2014 Apr 01; 32(4):921-8. PubMed ID: 24406778 [Abstract] [Full Text] [Related]
37. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, Clark LT, Ofili EO, Randall OS, Oikarinen L, Viitasalo M, Toivonen L, Julius S, Dahlöf B, Devereux RB. Am J Hypertens; 2002 Aug 01; 15(8):663-71. PubMed ID: 12160187 [Abstract] [Full Text] [Related]
39. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study]. González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA. Rev Esp Cardiol; 2007 Feb 01; 60(2):148-56. PubMed ID: 17338880 [Abstract] [Full Text] [Related]
40. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis. Yu Z, Song J, Cheng L, Li S, Lu Q, Zhang Y, Lin X, Liu D. PLoS One; 2021 Feb 01; 16(1):e0246305. PubMed ID: 33513186 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]